The CTSA funding to the Michigan Institute for Clinical and Health Research (MICHR) in 2007 marked the beginning of a transformation of clinical-translational research (CTR) at the University of Michigan (UM). This award, coupled with strong institutional support and growing faculty engagement, enabled UM to evolve from a predominantly basic science research institution to one with a comprehensive research portfolio. This has been achieved on the foundation of: integrated and innovative training and educational programs that have touched nearly 2,000 trainees, faculty and staff;centralization and optimization of previously fragmented research services to create innovative opportunities for users;$10.2M distributed for pilot studies to accelerate innovation;and researcher participation in new partnerships with our communities and across the CTSA National Consortium. In the renewal period, CTSA funding leveraged with robust institutional support will enable MICHR to pursue 5 Overarching Objectives: 1) Optimize training and mentoring to create the next generation of research teams and clinical and translational investigators;2) Augment infrastructure and refine research services to reduce barriers and maximize research productivity across the entire translational research continuum;3) Foster collaborations and leverage innovative approaches and technologies to catalyze discovery;4) Enhance community- and practice-based partnerships to assure bi-directional learning, research, and implementation of findings to benefit health;5) Actively lead and contribute to national CTSA Consortium activities and engage in cross-CTSA collaborations. These will be achieved by: expanding education into new areas to strengthen the pipeline of CTR investigators and deploying more flexible training tools;strer^gthening existing services and launching new ones to impact study start-up times and recruitment;employing major informatics investments to fully integrate the needs of CTR investigators into IT landscape;utilizing new practice-based research networl

Public Health Relevance

Translating scientific discoveries into real health gains is challenging. In recent decades this translation has been tal

National Institute of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
Linked Training Award (TL1)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Program Officer
Sawczuk, Andrea
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Schools of Medicine
Ann Arbor
United States
Zip Code
Kirk, Peter S; Borza, Tudor; Shahinian, Vahakn B et al. (2018) The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer. BJU Int 121:558-564
Porath, Jonathan D; Meka, Arjun P; Morrow, Chelsea et al. (2018) Patient Preferences for Diagnostic Testing in the Emergency Department: A Cross-sectional Study. Acad Emerg Med 25:627-633
Kirk, Peter S; Borza, Tudor; Dupree, James M et al. (2018) Potential Savings in Medicare Part D for Common Urological Conditions. Urol Pract 5:351-359
Tso, Ivy F; Taylor, Stephan F; Grove, Tyler B et al. (2017) Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program. Early Interv Psychiatry 11:14-22
Valikodath, Nita G; Newman-Casey, Paula Anne; Lee, Paul P et al. (2017) Agreement of Ocular Symptom Reporting Between Patient-Reported Outcomes and Medical Records. JAMA Ophthalmol 135:225-231
Kirk, Peter S; Govani, Shail; Borza, Tudor et al. (2017) Implications of Prostate Cancer Treatment in Men With Inflammatory Bowel Disease. Urology 104:131-136
Camaj, Anton; Zahuranec, Darin B; Paone, Gaetano et al. (2017) Organizational Contributors to the Variation in Red Blood Cell Transfusion Practices in Cardiac Surgery: Survey Results From the State of Michigan. Anesth Analg 125:975-980
Salata, Brian M; Hutton, David W; Levine, Deborah A et al. (2016) Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ? 65 Years With Nonvalvular Atrial Fibrillation. Am J Cardiol 117:54-60
Virani, Shama; Light, Emily; Peterson, Lisa A et al. (2016) Stability of methylation markers in head and neck squamous cell carcinoma. Head Neck 38 Suppl 1:E1325-31
Akkina, Sarah R; Novis, Sarah J; Keshavarzi, Nahid R et al. (2016) Academic institution pilot study shows far fewer diagnoses of sinusitis than reported nationally. Laryngoscope Investig Otolaryngol 1:124-129

Showing the most recent 10 out of 25 publications